SONIDA SENIOR LIVING INC (SNDA) Stock Fundamental Analysis
USA - NYSE:SNDA - US1404752032 - Common Stock
25.82 USD
+0.29 (+1.14%)
Overall SNDA gets a fundamental rating of 1 out of 10. We evaluated SNDA against 101 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of SNDA have multiple concerns. SNDA does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year SNDA has reported negative net income.
SNDA had a positive operating cash flow in the past year.
SNDA had negative earnings in 4 of the past 5 years.
SNDA had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -4.59%, SNDA is doing worse than 67.33% of the companies in the same industry.
With a Return On Equity value of -36.12%, SNDA is not doing good in the industry: 71.29% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.59% | ||
| ROE | -36.12% | ||
| ROIC | N/A |
ROA(3y)-4.67%
ROA(5y)-8.15%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
SNDA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
SNDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
SNDA has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SNDA has more shares outstanding
SNDA has a better debt/assets ratio than last year.
2.2 Solvency
SNDA has an Altman-Z score of 0.01. This is a bad value and indicates that SNDA is not financially healthy and even has some risk of bankruptcy.
SNDA has a worse Altman-Z score (0.01) than 79.21% of its industry peers.
A Debt/Equity ratio of 6.12 is on the high side and indicates that SNDA has dependencies on debt financing.
SNDA has a worse Debt to Equity ratio (6.12) than 81.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 6.12 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.01 |
ROIC/WACCN/A
WACC8.64%
2.3 Liquidity
SNDA has a Current Ratio of 0.85. This is a bad value and indicates that SNDA is not financially healthy enough and could expect problems in meeting its short term obligations.
SNDA has a Current ratio of 0.85. This is amonst the worse of the industry: SNDA underperforms 82.18% of its industry peers.
SNDA has a Quick Ratio of 0.85. This is a bad value and indicates that SNDA is not financially healthy enough and could expect problems in meeting its short term obligations.
SNDA's Quick ratio of 0.85 is on the low side compared to the rest of the industry. SNDA is outperformed by 72.28% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.85 | ||
| Quick Ratio | 0.85 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 57.60% over the past year.
Looking at the last year, SNDA shows a small growth in Revenue. The Revenue has grown by 4.96% in the last year.
The Revenue has been decreasing by -7.41% on average over the past years.
EPS 1Y (TTM)57.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.4%
Revenue 1Y (TTM)4.96%
Revenue growth 3Y9.04%
Revenue growth 5Y-7.41%
Sales Q2Q%18.19%
3.2 Future
SNDA is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.45% yearly.
SNDA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.60% yearly.
EPS Next Y17.59%
EPS Next 2Y3.5%
EPS Next 3Y5.45%
EPS Next 5YN/A
Revenue Next Year27.28%
Revenue Next 2Y16.25%
Revenue Next 3Y12.6%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
SNDA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SNDA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SNDA is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 31.78 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.5%
EPS Next 3Y5.45%
5. Dividend
5.1 Amount
SNDA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:SNDA (10/31/2025, 1:16:58 PM)
25.82
+0.29 (+1.14%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners82.2%
Inst Owner Change0.01%
Ins Owners19.1%
Ins Owner Change3.21%
Market Cap485.93M
Revenue(TTM)352.13M
Net Income(TTM)-38990000
Analysts43.33
Price Target26.52 (2.71%)
Short Float %1.6%
Short Ratio11.25
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.21
Dividend Growth(5Y)N/A
DP-14.45%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)50.21%
Min EPS beat(2)20.54%
Max EPS beat(2)79.89%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.32%
EPS NY rev (1m)0%
EPS NY rev (3m)20.26%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.38 | ||
| P/FCF | N/A | ||
| P/OCF | 38.59 | ||
| P/B | 4.5 | ||
| P/tB | 5.76 | ||
| EV/EBITDA | 31.78 |
EPS(TTM)-2.4
EYN/A
EPS(NY)-2.8
Fwd EYN/A
FCF(TTM)-0.96
FCFYN/A
OCF(TTM)0.67
OCFY2.59%
SpS18.71
BVpS5.74
TBVpS4.48
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.59% | ||
| ROE | -36.12% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-4.67%
ROA(5y)-8.15%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 6.12 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 18.33 | ||
| Cap/Depr | 59.55% | ||
| Cap/Sales | 8.69% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 34.97% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.85 | ||
| Quick Ratio | 0.85 | ||
| Altman-Z | 0.01 |
F-Score4
WACC8.64%
ROIC/WACCN/A
Cap/Depr(3y)55.33%
Cap/Depr(5y)43.9%
Cap/Sales(3y)8.53%
Cap/Sales(5y)6.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.4%
EPS Next Y17.59%
EPS Next 2Y3.5%
EPS Next 3Y5.45%
EPS Next 5YN/A
Revenue 1Y (TTM)4.96%
Revenue growth 3Y9.04%
Revenue growth 5Y-7.41%
Sales Q2Q%18.19%
Revenue Next Year27.28%
Revenue Next 2Y16.25%
Revenue Next 3Y12.6%
Revenue Next 5YN/A
EBIT growth 1Y-37.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year676.24%
EBIT Next 3Y112.63%
EBIT Next 5YN/A
FCF growth 1Y-5.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y150.41%
OCF growth 3YN/A
OCF growth 5YN/A
SONIDA SENIOR LIVING INC / SNDA FAQ
What is the fundamental rating for SNDA stock?
ChartMill assigns a fundamental rating of 1 / 10 to SNDA.
What is the valuation status of SONIDA SENIOR LIVING INC (SNDA) stock?
ChartMill assigns a valuation rating of 0 / 10 to SONIDA SENIOR LIVING INC (SNDA). This can be considered as Overvalued.
What is the profitability of SNDA stock?
SONIDA SENIOR LIVING INC (SNDA) has a profitability rating of 0 / 10.
What is the financial health of SONIDA SENIOR LIVING INC (SNDA) stock?
The financial health rating of SONIDA SENIOR LIVING INC (SNDA) is 0 / 10.
How sustainable is the dividend of SONIDA SENIOR LIVING INC (SNDA) stock?
The dividend rating of SONIDA SENIOR LIVING INC (SNDA) is 0 / 10 and the dividend payout ratio is -14.45%.